Literature DB >> 6153259

Evaluation of aggressive surgery for carcinoma of the extrahepatic bile ducts.

A Evander, P Fredlund, J Hoevels, I Ihse, S Bengmark.   

Abstract

The records of 80 consecutive patients with extrahepatic bile duct cancer, 45 women and 35 men, median age 70 years (33-89 years), were reviewed. The histologic diagnoses were adenocarcinoma in 45 patients, 34 cholangiocarcinoma and one squamous cell carcinoma. In 34 patients the tumor was located to the confluence, the right or left hepatic duct, in 16 to the middle and in four to the distal portion of the bile duct. In the remaining 26 patients the tumor comprised more than one of these locations (mixed location). Twenty-seven of the 80 patients (34%) were operated on with resection of the tumor. Among patients 70 years of age and younger the resectability rate was 57%. In nine patients the main surgical procedure was bile duct resection, in 15 patients bile duct resection and liver lobe resection, in 2 patients total pancreatectomy and in one local excision were performed. The resection of the tumor was regarded as radical in 12 patients and palliative in 15. The mortality rate was 11% after resection as compared to 30% in patients with nonresectable tumors. The most common postoperative complication was insufficiency of the anastomosis which occurred in seven patients. Three of these patients required reoperation. The median survival time in patients operated on with radical resection was 20 months, palliative resection 7(1/2) months and in patients with nonresectable tumors 2(1/2) months. The quality of life was estimated according to a special schedule and was found to be improved after resection as compared to nonresection. Patients operated with radical resection spent significantly less of their remaining life at hospital as compared to palliatively resected patients or patients with nonresectable tumors.

Entities:  

Mesh:

Year:  1980        PMID: 6153259      PMCID: PMC1344612          DOI: 10.1097/00000658-198001000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  17 in total

1.  Carcinoma of the extrahepatic biliary tract.

Authors:  W P Longmire; M S McArthur; E A Bastounis; J Hiatt
Journal:  Ann Surg       Date:  1973-09       Impact factor: 12.969

2.  Angiography in carcinoma of the biliary tract.

Authors:  S R Reuter; H C Redman; J J Bookstein
Journal:  Br J Radiol       Date:  1971-08       Impact factor: 3.039

3.  U tube drainage in the palliative therapy of carcinoma of the main hepatic duct junction.

Authors:  J Terblanche; J H Louw
Journal:  Surg Clin North Am       Date:  1973-10       Impact factor: 2.741

4.  Carcinoma of the proximal bile ducts.

Authors:  A P Ross; J W Braasch; K W Warren
Journal:  Surg Gynecol Obstet       Date:  1973-06

5.  Modification of the Longmire procedure.

Authors:  J L Cameron; B W Gayler; D P Harrington
Journal:  Ann Surg       Date:  1978-04       Impact factor: 12.969

6.  Experience with percutaneous transhepatic cholangiography using the Japanese needle.

Authors:  J Ariyama; H Shirakabe; K Ohashi; G M Roberts
Journal:  Gastrointest Radiol       Date:  1978-02-23

7.  Percutaneous cytodiagnosis of carcinoma of the pancreas and bile duct.

Authors:  A Evander; I Ihse; A Lunderquist; U Tylén; M Akerman
Journal:  Ann Surg       Date:  1978-07       Impact factor: 12.969

8.  Total pancreatectomy for cancer. An appraisal of 65 cases.

Authors:  I Ihse; P Lilja; B Arnesjö; S Bengmark
Journal:  Ann Surg       Date:  1977-12       Impact factor: 12.969

9.  Percutaneous transhepatic intubation of bile ducts for combined internal-external drainage in preoperative and palliative treatment of obstructive jaundice.

Authors:  J Hoevels; A Lunderquist; I Ihse
Journal:  Gastrointest Radiol       Date:  1978-04-15

10.  Carcinoma of the proximal bile ducts.

Authors:  T Tsuzuki; M Uekusa
Journal:  Surg Gynecol Obstet       Date:  1978-06
View more
  29 in total

1.  Major liver resection for hilar cholangiocarcinoma.

Authors:  S Bengmark; H Ekberg; A Evander; B Klofver-Stahl; K G Tranberg
Journal:  Ann Surg       Date:  1988-02       Impact factor: 12.969

2.  Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases.

Authors:  J C Flickinger; A H Epstein; S Iwatsuki; B I Carr; T E Starzl
Journal:  Cancer       Date:  1991-07-15       Impact factor: 6.860

3.  Management strategies in resection for hilar cholangiocarcinoma.

Authors:  H Bismuth; R Nakache; T Diamond
Journal:  Ann Surg       Date:  1992-01       Impact factor: 12.969

4.  Radical surgery for right-sided klatskin tumor.

Authors:  P Neuhaus; A Thelen
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

5.  Proximal bile duct cancer: high resectability rate and 5-year survival.

Authors:  B Launois; J Terblanche; M Lakehal; J M Catheline; E Bardaxoglou; S Landen; J P Campion; F Sutherland; B Meunier
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

6.  Bile duct carcinoma. Diagnosis and treatment.

Authors:  D G Gibby; J B Hanks; H J Wanebo; D L Kaiser; C J Tegtmeyer; J G Chandler; R S Jones
Journal:  Ann Surg       Date:  1985-08       Impact factor: 12.969

7.  Clinicopathological aspects of high bile duct cancer. Experience with resection and bypass surgical treatments.

Authors:  R M Beazley; N Hadjis; I S Benjamin; L H Blumgart
Journal:  Ann Surg       Date:  1984-06       Impact factor: 12.969

8.  Primary adenocarcinoma of the bile ducts. Clinical characteristics and natural history.

Authors:  J T Bruggen; M S McPhee; P S Bhatia; J M Richter
Journal:  Dig Dis Sci       Date:  1986-08       Impact factor: 3.199

9.  Carcinoma of the proximal extrahepatic biliary tree radiologic assessment and therapeutic alternatives.

Authors:  C R Voyles; N J Bowley; D J Allison; I S Benjamin; L H Blumgart
Journal:  Ann Surg       Date:  1983-02       Impact factor: 12.969

10.  Radiotherapy of cholangiocarcinoma: the roles for primary and adjuvant therapies.

Authors:  T Shiina; S Mikuriya; T Uno; T Toita; S Serizawa; J Itami; S Kawai; M Tani
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.